Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
Chem Commun (Camb). 2022 Mar 1;58(18):3051-3054. doi: 10.1039/d1cc07298f.
A Ag(I)/PPh-catalyzed chelation-controlled cycloisomerization of tryptamine-ynamide was developed to access the spiro[indole-3,4'-piperidine] scaffold in a racemic and diastereoselective manner. The diastereoselective products were achieved by a chiron approach. Density functional theory (DFT) calculations indicated that strong non-covalent effects between the substrate and catalyst/ligand complex stabilized the spiroindoleninium intermediate cation-π-π interactions.
Ag(I)/PPh 催化的色胺-内酰胺螯合控制环化异构化反应被开发出来,以非对映选择性的方式获得螺[吲哚-3,4'-哌啶]骨架。通过前手性方法获得非对映选择性产物。密度泛函理论(DFT)计算表明,底物和催化剂/配体复合物之间的强非共价相互作用稳定了螺吲哚啉鎓中间体的阳离子-π-π相互作用。